This site uses several types of cookies to offer our services. By clicking on “Accept all”, you declare your consent to the use of all cookies. You can also declare your consent by individually clicking on the sliders for each category of cookies and save these preferences by clicking on “Save”. In case you do not click any of the sliders, then only the necessary cookies are used. Further information can be found in our privacy policy.
Our founders have spent 15 years running a successful industry-independent procurement consulting business. With a proven track record, our combined experience adds up to over 100 consulting years, spent acquiring industry-specific knowledge and expertise in 15 European Countries. Now, we will apply these skills to the task of bringing about meaningful change in the procurement and distribution of medical devices.
We currently work in 15 European countries, for clients including 6 private equity investors
100 combined years of consulting experience, and approx. 200 procurement projects undertaken in the last 15 years
Track record: > 20-60% permanent savings p.a.
Successful projects (highlights from the past 3 years):
140 rehab, acute, and care locations - 40m € purchasing volume p.a.
Our new business model is the next logical development step. Instead of standardizing and bundling medical devices to increase purchasing power for individual European Hospital Groups via traditional paper-based contracts, procurement can be done on a European scale by deploying our platform technology. This means that every participating European Hospital stands to make financial savings thanks to increased purchasing power, guided by the internet platform economy approach and rules.
Product range and risk classification for implants and medical consumables
The main focus of our platform is medical implants and consumables. In accordance with European Union Medical Device Regulations (MDR), they are grouped into 3 classes of risk classification: Read more
Class
Description of the risk
examples
III
Particularly high methodological risk
For long-term drug delivery
Ingredients of animal origin and in the body
Direct application to the heart, central circulatory system or central nervous system and naturally invasive contraception
Use of the international German, Austrian, Swiss, French, Italian, Swedish, Norwegian, Danish, Finnish, British, Irish, Benelux, Portuguese, Polish and CEE Article and Price Database (> 10,000,000 single product data)
We supplement product information with more than 70 product features, to create 1:1 comparisons and “medical decision-making tools
This provides us with the same knowledge level as doctors, enabling us to enter discussions as equals, because:
We can ask the right questions
We can verify manufacturers' claims
We can prevent the wrong products from being used or we can prevent the levelling upwards.
Use of EU-compliant, manufacturer-neutral specifications for all tenders are available for all medical product groups
Benefits for our customers
Strengthening of own position
Organisation of supplier meetings
Derivation of the savings potential
1:1 article comparisons are possible thanks to the creation of exact benchmarks
Creation of medical expert groups and EU-compliant tender specifications
Easy creation of '1:1 substitutions savings simulation’ / Financial savings through simple substitutions
There is no excuse for doctors to break off the discussion